Astrazeneca

Britain’s second-biggest drugmaker to improve Macclesfield facilities but is still not committing to manufacturing expansio.

Roche’s BLA

The US Food and Drug Administration (FDA) has accepted Roche’s biologics licence application (BLA) and granted priority review for emicizumab […]

Victoza News

The FDA has spoken: Novo Nordisk’s diabetes fighter Victoza officially reduces the risk of heart attack, stroke and cardiovascular death, […]